Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Cited by CrossRef (13)

  1. Hidekazu Suzuki, Juntaro Matsuzaki. Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?: Author's Reply. J Neurogastroenterol Motil 2012;18:459
    https://doi.org/10.5056/jnm.2012.18.4.459
  2. Kyu Shik Kim, Hyung-Jee Kim, Seong Ho Lee, Sung Tae Cho, Hong Sang Moon. Association Between Irritable Bowel Syndrome and Overactive Bladder: A Research Survey. Urology 2017;109:88
    https://doi.org/10.1016/j.urology.2017.06.038
  3. Michael Camilleri, Lionel Buéno, Viola Andresen, Fabrizio De Ponti, Myung-Gyu Choi, Anthony Lembo. Pharmacologic, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders. Gastroenterology 2016;150:1319
    https://doi.org/10.1053/j.gastro.2016.02.029
  4. Hidekazu Suzuki. To establish a treatment for GI symptoms of cystic fibrosis, it is necessary to develop a symptom evaluation tool. United European Gastroenterol. j. 2019;7:873
    https://doi.org/10.1177/2050640619856188
  5. Magnus Simrén, Jan Tack. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 2018;15:589
    https://doi.org/10.1038/s41575-018-0034-5
  6. Tuan-Pin Yueh, Fong-Ying Chen, Tsyr-En Lin, Mao-Te Chuang. Diarrhea after laparoscopic cholecystectomy: Associated factors and predictors. Asian Journal of Surgery 2014;37:171
    https://doi.org/10.1016/j.asjsur.2014.01.008
  7. Michael Camilleri. Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. J. Clin. Invest. 2013;123:4111
    https://doi.org/10.1172/JCI70837
  8. Sheyda Ranjbar, Seyed Afshin Seyednejad, Shekoufeh Nikfar, Roja Rahimi, Mohammad Abdollahi. How can we develop better antispasmodics for irritable bowel syndrome?. Expert Opinion on Drug Discovery 2019;14:549
    https://doi.org/10.1080/17460441.2019.1593369
  9. Full-Young Chang. Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?. J Neurogastroenterol Motil 2012;18:457
    https://doi.org/10.5056/jnm.2012.18.4.457
  10. Mari Kimoto, Jorge L. Zeredo, Masato S. Ota, Zenro Nihei, Kazuo Toda. Comparison of stress-induced modulation of smooth-muscle activity between ileum and colon in male rats. Autonomic Neuroscience 2014;183:8
    https://doi.org/10.1016/j.autneu.2014.01.008
  11. Agata Szymaszkiewicz, Marta Zielińska. A Comprehensive Overview of Irritable Bowel Syndrome. 2014.
    https://doi.org/10.1016/B978-0-12-821324-7.00011-3
  12. Akhilesh Wadhwa, Michael Camilleri, Madhusudan Grover. New and Investigational Agents for Irritable Bowel Syndrome. Curr Gastroenterol Rep 2015;17
    https://doi.org/10.1007/s11894-015-0473-x
  13. Emanuele Sinagra, Gaetano Cristian Morreale, Ghazaleh Mohammadian, Giorgio Fusco, Valentina Guarnotta, Giovanni Tomasello, Francesco Cappello, Francesca Rossi, Georgios Amvrosiadis, Dario Raimondo. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. WJG 2017;23:6593
    https://doi.org/10.3748/wjg.v23.i36.6593